Ascendis Pharma AS logo

Ascendis Pharma AS

ASND
Healthcare|Biotechnology|Denmark
$270.51
-5.15 (-1.87%)
Tangible Book
$9.06
Graham Number
$44.64

About

Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.

Stock Price

+10.2%(1Y)

Pipeline Summary

0 total trials
0
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4

BioScore

5.8/10
Watchlist

Ownership

Recent Insider Trades

SMITH SCOTT THOMASBUY
2026-06-02100 shares @ $219
BIENAIME JEAN JACQUESBUY
2026-05-29500 shares @ $223.12
SMITH SCOTT THOMASBUY
2026-05-29250 shares @ $223.32
BIENAIME JEAN JACQUESBUY
2026-05-26400 shares @ $237.8
JENSEN FLEMMING STEENSELL
2026-05-1119,460 shares @ $238.49

Recent News

2026-07-07 16:33:53
2026-06-30 13:32:41
2026-06-26 21:55:54
2026-06-26 20:50:24
2026-06-14 21:27:37
Data last updated: Jul 12, 2026, 07:28 PM